Cingulate plans Board reshuffle and size cut
Cingulate Inc. reported planned changes to its Board of Directors.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cingulate Inc. reported planned changes to its Board of Directors. Class II directors Jeff Ervin and Jay Roberts will not seek re-election when their terms expire at the Company’s 2026 Annual Meeting of Stockholders, as the company moves to reduce the size of the Board.
On May 18, 2026, the Board accepted the resignation of Class I director Jeff Hargroves and immediately re-appointed him as a Class II director to align director classes with the company’s certificate of incorporation. The Board intends to reduce the Board to five directors, appoint a new chairman on the meeting date, and has nominated Mr. Hargroves to stand for election as a Class II director alongside existing Class I directors Peter Werth and Frederick Jiang.
8-K Event Classification
Key Figures
Key Terms
Class II directors financial
Annual Meeting of Stockholders financial
certificate of incorporation regulatory
emerging growth company regulatory
Nasdaq Capital Market financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What board changes did Cingulate (CING) announce in this 8-K?
Why did Cingulate (CING) reclassify director Jeff Hargroves as a Class II director?
How will Cingulate’s (CING) Board composition look after the planned changes?
Did Cingulate (CING) name a new Board chairman in this filing?
Does this Cingulate (CING) 8-K involve any financial transactions or earnings data?
AI-generated analysis. How Rhea-AI works. Not financial advice.